Topic: LUMIRADX
4 results were found.
Roche to acquire LumiraDx's Point of Care technology for $295 million plus up to $55 million - December 31, 2023
LumiraDx receives UK MHRA approval for SARS-CoV-2 RNA STAR Complete - February 22, 2022
LumiraDx's COVID-19 antigen test detects Omicron variant - January 14, 2022
LumiraDx CRP Test achieves CE Marking - January 11, 2022